Ranking Alexa Global: # 15,648,599
The main IP address: 194.185.38.106,Your server Italy,Milan ISP:Neuronica S.r.l. TLD:com CountryCode:IT
The description :cosmo is a specialty pharmaceutical company that aims to become a global leader in the market of optimized therapies for selected gastro-intestinal diseases. the company’s proprietary clinical develop...
This report updates in 13-Jun-2018
Created Date: | 2004-09-22 |
Changed Date: | 2016-07-24 |
Expires Date: | 2017-09-22 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host cosmopharmaceuticals.com. Currently, hosted in Italy and its service provider is Neuronica S.r.l. .
Latitude: | 45.46427154541 |
Longitude: | 9.189510345459 |
Country: | Italy (IT) |
City: | Milan |
Region: | Lombardia |
ISP: | Neuronica S.r.l. |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called containing the details of what the browser wants and will accept back from the web server.
X-CDN: | Incapsula |
Via: | 1.1 2ee0fe9a0480e5e9a23a7364903f489e.cloudfront.net (CloudFront) |
X-Cache: | Miss from cloudfront |
Content-Encoding: | gzip |
Transfer-Encoding: | chunked |
Set-Cookie: | ASP.NET_SessionId=533p4osdmvlszn2mdndnr4fp; path=/; HttpOnly, AWSELB=CB5BA17516844C442AC288F8007AE9948CA0D8C8F7DD19F45230172E53CDAD7159E17323CCD922BD3F9680EBC68B7C9565CDF3CE016A609BFAF923C03A1A01D2E0B7A08FD4;PATH=/, visid_incap_987024=riA24IvpSPmLMCwvy8Uy4BjhIFsAAAAAQUIPAAAAAACPDLJBAV7JxQvrav7aBJlM; expires=Wed, 12 Jun 2019 13:08:27 GMT; path=/; Domain=.cosmopharmaceuticals.com, nlbi_987024=QzobKUkFzkdcTD3BN2MJ8gAAAADmjYESN6+kGkFQgqL75Oc5; path=/; Domain=.cosmopharmaceuticals.com, incap_ses_703_987024=rGWzLnRADCGymDwdUZrBCRjhIFsAAAAAsYZv0JFQrvzertz5vwOiqw==; path=/; Domain=.cosmopharmaceuticals.com |
Expires: | -1 |
Server: | |
Connection: | keep-alive |
X-Amz-Cf-Id: | OeiuoHjGnYyARDQNINO8iv6ZeD1Zikk_UyGsuQGY526yTRYI3h3Owg== |
Pragma: | no-cache |
Cache-Control: | no-cache, no-cache="set-cookie" |
Date: | Wed, 13 Jun 2018 09:17:13 GMT |
X-Iinfo: | 7-7766208-7766217 NNNN CT(1 -1 0) RT(1528881431842 0) q(0 3 3 0) r(4 4) U5 |
X-Frame-Options: | SAMEORIGIN |
Content-Type: | text/html; charset=utf-8 |
soa: | ns-cloud-b1.googledomains.com. hostmaster.neuronica.it. 2016050404 86400 7200 604800 3600 |
txt: | "v=spf1 -all" "MS=ms34436760" "hy2MveYRYy66cZzCuaBGiCKDocAF8JU6KLxoNCioFlCS53WTOd6WOHJWdC25wEcNAXv9PdB8D7sLcEpqZtuwzg==" |
ns: | ns-cloud-b1.googledomains.com. ns-cloud-b2.googledomains.com. ns-cloud-b3.googledomains.com. ns-cloud-b4.googledomains.com. |
ipv4: | IP:194.185.38.106 ASN:3313 OWNER:INET-AS, IT Country:IT |
mx: | MX preference = 10, mail exchanger = mx5.elmecnet.net. MX preference = 20, mail exchanger = mx4.elmecnet.net. |
skip to main content home company therapeutic focus strategy history management activities patents product pipeline manufacturing technology investor relations share information ownership structure key financial data financial reports presentations annual general meeting disclosure of equity interest management transactions corporate governance analyst coverage financial calendar & events dividend 2017 ir contact news & media press releases & company news multimedia gallery nice to know contact careers current job openings home company therapeutic focus treatment of the diseases ulcerative colitis crohn's disease colon infections prevention of colon cancer strategy history management board of directors general management activities patents product pipeline lialda ® / mezavant ® / mesavancol ® uceris ® / cortiment ® aemcolo lumeblue eleview™ zacol nmx®- nutraceutical manufacturing technology investor relations share information share price chart share price table ownership structure key financial data financial reports historical data presentations annual general meeting disclosure of equity interest management transactions corporate governance management scientific advisory board articles of association auditors analyst coverage financial calendar & events dividend 2017 ir contact news & media press releases & company news multimedia gallery nice to know contact careers current job openings strategy cosmo is a specialty pharmaceutical company focused in treating selected gastrointestinal disorders. discover more about our strategic approaches. find out more eleview now available in the us find out more product pipeline the company is developing a range of pharmaceutical products that are based on new chemical entities and are targeted on skin diseases that can be topically treated. find out more therapeutic focus inflammatory bowel diseases (ibd) are a group of chronic, progressive, recurring and debilitating disorders characterized by severe damage of the gastro-intestinal tract. find out more cosmo pharmaceuticals nv latest news 30/05/2018 cosmo pharmaceuticals’ shareholders approve all agenda items at annual general meeting 23/05/2018 cosmo pharmaceuticals receives complete response letter from the fda on methylene blue mmx nda 18/05/2018 fda accepts new drug application submission for cosmo pharmaceutical’s rifamycin sv mmx and sets pdufa date for november 16, 2018 read all news articles welcome to cosmo cosmo is a specialty pharmaceutical company that aims to become a global leader in the market of optimized therapies for selected gastro-intestinal diseases. the company’s proprietary clinical development pipeline specifically addresses innovative treatments for gastro-intestinal diseases. read more about us share price share price information therapeutic focus inflammatory bowel diseases (ibd) are a group of chronic, progressive, recurring and debilitating disorders characterized by severe damage of the gastro-intestinal tract. read more upcoming event more events product pipeline financial data multimedia contact get in touch with us today. © 2018 cosmo pharmaceuticals remote support contact us disclaimer privacy accessibility alert service site map home company activities investor relations news & media careers
http://www.cosmopharmaceuticals.com///investor-relations/disclosure-of-equity-interest
http://www.cosmopharmaceuticals.com///investor-relations/management-transactions
http://www.cosmopharmaceuticals.com///investor-relations/share-information/share-price-table
http://www.cosmopharmaceuticals.com///company/therapeutic-focus/colon_infections
http://www.cosmopharmaceuticals.com///activities/product-pipeline/eleview
http://www.cosmopharmaceuticals.com//#maincontent
http://www.cosmopharmaceuticals.com///investor-relations/financial-calendar-and-events
http://www.cosmopharmaceuticals.com///activities/product-pipeline
http://www.cosmopharmaceuticals.com///company/therapeutic-focus
http://www.cosmopharmaceuticals.com///investor-relations/annual-general-meeting/2018
http://www.cosmopharmaceuticals.com///news-and-media/press-releases-and-company-news/2018/23052018
http://www.cosmopharmaceuticals.com///site-services/privacy
http://www.cosmopharmaceuticals.com///news-and-media/press-releases-and-company-news/2018/180530
http://www.cosmopharmaceuticals.com///investor-relations/corporate-governance/scientific-advisory-board
http://www.cosmopharmaceuticals.com///investor-relations
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Welcome to the Network Solutions(R) Registrar WHOIS Server.
The IP address from which you have visited the Network Solutions Registrar WHOIS
database is contained within a list of IP addresses that may have failed
to abide by Network Solutions' WHOIS policy. Failure to abide by this policy can
adversely impact our systems and servers, preventing the processing of
other WHOIS requests.
To see the Network Solutions WHOIS Policy, click on or copy and paste the following
URL into your browser:
http://www.networksolutions.com/whois/index.jhtml
If you feel that you have received this message in error, please email us using the online
form at http://www.networksolutions.com/help/email.jsp with the following information:
Whois Query: cosmopharmaceuticals.com
YOUR IP address is 45.33.85.57
Date and Time of Query: Fri Jul 14 05:57:37 EDT 2017
Reason Code: IE
REGISTRAR NETWORK SOLUTIONS, LLC.
REFERRER http://networksolutions.com
SERVERS
SERVER com.whois-servers.net
ARGS domain =cosmopharmaceuticals.com
PORT 43
SERVER whois.networksolutions.com
ARGS cosmopharmaceuticals.com
PORT 43
TYPE domain
DOMAIN
NAME cosmopharmaceuticals.com
NSERVER
RELAY1.NEURONICA.IT 194.185.38.4
RELAY2.NEURONICA.IT 194.185.38.2
STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
CHANGED 2016-07-24
CREATED 2004-09-22
EXPIRES 2017-09-22
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .